BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 2861749)

  • 1. Norepinephrine-induced beta 1-adrenergic peripheral vasodilation in conscious dogs.
    Vatner SF; Knight DR; Hintze TH
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H49-56. PubMed ID: 2861749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baroreflex mechanisms buffering alpha-adrenergic agonists in conscious dogs.
    Fujii AM; Vatner SF
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H728-36. PubMed ID: 2889369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I(f) current mediates beta-adrenergic enhancement of heart rate but not contractility in vivo.
    Guth BD; Dietze T
    Basic Res Cardiol; 1995; 90(3):192-202. PubMed ID: 7575372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary blood flow changes following activation of adrenergic receptors in the conscious dog.
    Gwirtz PA; Stone HL
    Am J Physiol; 1982 Jul; 243(1):H13-9. PubMed ID: 6283918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-adrenoceptor blockade by phentolamine causes beta-adrenergic vasodilation by increased catecholamine release due to presynaptic alpha-blockade.
    Saeed M; Sommer O; Holtz J; Bassenge E
    J Cardiovasc Pharmacol; 1982; 4(1):44-52. PubMed ID: 6176798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of large coronary vessels by adrenergic mechanisms in conscious dogs.
    Vatner SF; Macho P
    Basic Res Cardiol; 1981; 76(5):508-17. PubMed ID: 6272684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors.
    Yorikane R; Kanda A; Kimura T; Satoh S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of morphine on coronary and left ventricular dynamics in conscious dogs.
    Vatner SF; Marsh JD; Swain JA
    J Clin Invest; 1975 Feb; 55(2):207-17. PubMed ID: 236324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog.
    Vatner SF; Hintze TH; Macho P
    Circ Res; 1982 Jul; 51(1):56-66. PubMed ID: 6282497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial modulation of beta-adrenergic dilation of large coronary arteries in conscious dogs.
    Ghaleh B; Béa ML; Dubois-Randé JL; Giudicelli JF; Hittinger L; Berdeaux A
    Circulation; 1995 Nov; 92(9):2627-35. PubMed ID: 7586366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine attenuates both alpha-1 and alpha-2 adrenoceptor-mediated pressor and vasoconstrictor responses in conscious dogs and primates.
    Woodman OL; Constantine JW; Vatner SF
    J Pharmacol Exp Ther; 1986 Dec; 239(3):648-53. PubMed ID: 3025415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.
    Shen YT; Cervoni P; Claus T; Vatner SF
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1435-43. PubMed ID: 8819531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
    Woodman OL; Vatner SF
    J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor.
    Vatner DE; Vatner SF; Nejima J; Uemura N; Susanni EE; Hintze TH; Homcy CJ
    J Clin Invest; 1989 Dec; 84(6):1741-8. PubMed ID: 2556443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed beta-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure.
    Kiuchi K; Sato N; Shannon RP; Vatner DE; Morgan K; Vatner SF
    Circ Res; 1993 Dec; 73(6):1013-23. PubMed ID: 7693360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cardiac denervation on development of heart failure and catecholamine desensitization.
    Sato N; Vatner SF; Shen YT; Kudej RK; Ghaleh-Marzban B; Uechi M; Asai K; Mirsky I; Patrick TA; Shannon RP; Vatner DE
    Circulation; 1997 Apr; 95(8):2130-40. PubMed ID: 9133524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of beta-adrenergic agonists in the control of vascular capacitance.
    Rothe CF; Flanagan AD; Maass-Moreno R
    Can J Physiol Pharmacol; 1990 May; 68(5):575-85. PubMed ID: 1971191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.